“…1,3 In addition, there is continued interest in the application of CCC devices as a novel means of integrating reaction and separation steps. [4][5][6] In this work, we focus on the fractionation of a commercial erythromycin preparation consisting of a number of structurally similar analogues of the main product, erythromycin A (EA). Erythromycin is a macrolide antibiotic (MWt = 732 Da), produced commercially by large scale fermentation of the actinomycete, Sacchropolyspora erythrea.…”